Phase 3 Primary Breast Cancer Clinical Trials

2 recruitingPhase 3

What is a Phase 3 trial?

Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.

Showing 1–2 of 2 trials

Recruiting

Phase 3

A Phase III, Active-Controlled Study of SHR-A1811 Versus Trastuzumab Emtansine (T-DM1) in HER2-Positive Primary Breast Cancer Participants With Residual Invasive Disease Following Neoadjuvant Therapy

HER2-Positive Primary Breast Cancer Participants With Residual Invasive Disease Following Neoadjuvant Therapy

Jiangsu HengRui Medicine Co., Ltd.1,600 enrolled2 locationsNCT06126640

Completed

Phase 3

IBCSG 30-04 / NCIC CTG MA.27

Receptor positive primary breast cancer

Australia and New Zealand Breast Cancer Trials Group Ltd5,800 enrolled1 locationACTRN12605000389606